Long COVID in Primary Care: A Practical Approach to Evaluation and Management - Summary - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

A Practical Primary Care Guide to Assessing and Managing Long COVID

  • By

  • Anita Chopra

  • Hector F. Bonilla

  • Abby L. Cheng

  • October 9, 2026

Share

Objective:

Present a pragmatic primary-care framework for recognizing and evaluating Long COVID, counseling patients, initiating symptom-based management, and considering specialty referral.

Approach:
  • Review type: Narrative review presenting a pragmatic framework centered on primary care.
  • Clinical framing: Describes common symptom clusters and illustrative cases involving fatigue and post-exertional malaise, dysautonomia, and cognitive impairment.
  • Mechanism framework: Introduces a clinical framework that groups Long COVID manifestations into three categories; the supplied excerpt describes enduring effects of acute end-organ tissue injury and begins, but does not complete, its account of the second category.
Key Findings:
  • The review cites estimates that approximately 6% of US adults and 0.5% of children and adolescents experience new or persistently worsened symptoms that began soon after acute SARS-CoV-2 infection.
  • Frequently reported symptoms include fatigue, post-exertional malaise, cognitive impairment, and lightheadedness or orthostasis. Gastrointestinal symptoms, sleep disturbance, pain, and breathing discomfort may also occur.
  • In clinical settings, Long COVID may be conceptualized as new or worsened symptoms following confirmed or suspected acute SARS-CoV-2 infection that continue beyond three months.
  • The review notes that validated diagnostic biomarkers and curative treatment for Long COVID are lacking.
Interpretation:

The review presents Long COVID as a condition with varied symptoms and describes how recognizing common symptom clusters may facilitate identification of Long COVID and associated conditions, including ME/CFS and POTS.

Limitations:
  • The supplied context is truncated during the discussion of the proposed pathophysiological categories.

Original Source(s)

Related Content